ACTEMRA tocilizumab (rch) 80 mg/4 mL injection concentrated vial

Roche Products Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: c4d2132e055e9b73
Product Name: ACTEMRA tocilizumab (rch) 80 mg/4 mL injection concentrated vial
Artg Id: 149403
Artg Name: ACTEMRA tocilizumab (rch) 80 mg/4 mL injection concentrated vial
Sponsor: Roche Products Pty Ltd
Company Detail Path: /organization/roche-products-pty-ltd
Artg Date: 2009-05-21
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: REPI
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/c73e523db6dd5033ee10899a1495d25e.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/6c090b9948031f5beb9f7c953b22cdd5.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

c4d2132e055e9b73

Type

Standard